2020–2025 Council of the Convention

The Council of the Convention (CoC) is a global governance committee that represents the full USP Convention Membership. The CoC provides broad perspectives, contributing strategic leadership on critical membership, engagement and governance issues.

The CoC is composed of representatives from each of the six categories of Convention Voting Members, in addition to four members from the Council of Experts. To ensure a perspective representative of USP’s work, at the start of this cycle, the CoC is made up of:

  • The President of the Convention
  • Five members who chair each of the USP Convention Sectors
  • Four members who chair each of the USP Convention Regional Chapters
  • Nine members who serve in an at-large capacity

The CoC meets quarterly throughout the five-year cycle to conduct governance responsibilities, receive updates from staff on progress against Resolutions and other mission-driven work, and to discuss sector and chapter activities, challenges, insights, and best practices.

Council of the Convention Members

The President of the Convention

  • Dennis E. Doherty, M.D., Convention President and CoC Chair

USP Convention Sector Chairs

  • Generics Sector Chair: David Gaugh, R.Ph., Association for Accessible Medicines
  • Healthcare Practice Sector Chair: Amy Cadwallader, Ph.D., American Medical Association
  • Biologics Sector Chair: Susan Cantrell, BS Pharm., Academy of Managed Care Pharmacy
  • Excipients Sector Chair: Mary Kirchhoff, Ph.D., American Chemical Society
  • Dietary Supplements Sector Chair: Jay Sirois, Ph.D., Consumer Healthcare Products Association

USP Convention Regional Chapter Chairs

  • South Asia Region Chair: Bhojraj Suresh, M.Pharm., Ph.D., D.Sc. Pharmacy Council of India
  • Latin America Region Chair: Caroline Weinstein, Ph.D., Chilean Pharmacopeia
  • Greater China Region Chair: Mingzhe Xu, National Institutes for Food and Drug Control
  • Asia Pacific Region Chair: John Chien-Wei Lim, M.D., M.S., Centre of Regulatory Excellence, Duke-NUS Medical School*

At-Large Members

  • Emmanuel Akala, R. Ph., Ph.D., DIM, Howard University College of Pharmacy
  • Lynette Bradley-Baker, Ph.D., R.Ph., American Association of Colleges of Pharmacy
  • Keysha Brooks-Coley, M.A., American Cancer Society/Cancer Action Network
  • Barbara Exum, PharmD, Virginia Commonwealth University/Medical College of Virginia School of Pharmacy
  • Stephen Mullenix, BS Pharm., R.Ph., National Council for Prescription Drug Programs
  • Pallavi Nithyanandan, Ph.D., FDA Center for Drug Evaluation and Research
  • Sue Peschin, M.H.S., Alliance for Aging Research
  • Hanan Sboul, M.B.A., B. Pharm, CAE, Jordanian Association of Pharmaceutical Manufacturers
  • Kanecia Zimmerman, M.D., American Academy of Pediatrics

Council of Experts Representatives

  • Martin Coffey, Ph.D., USP General Chapters—Dosage Forms Expert Committee
  • Stephanie Crawford, M.P.H., Ph.D., USP Nomenclature and Labeling Expert Committee
  • Kim Huynh-Ba, M.S., B.Sc., USP Small Molecules 4 Expert Committee
  • Xiaorong He, MBA, Ph.D., M.S., B.S., USP General Chapters– Physical Analytical Methods Expert Committee

 

*Provisionally approved